Survivors of Adolescent, Young Adult Cancer Face Financial Hardships
THURSDAY, April 22, 2021 -- Adult survivors of adolescent and young adult (AYA) cancers are more likely to experience medical financial hardship compared with adults without a cancer history, according to a study published online April 12 in the Journal of the National Cancer Institute.
Amy D. Lu, M.D., from the University of Toronto, and colleagues used data from the 2010 to 2018 National Health Interview Surveys to identify 2,588 adult survivors of AYA cancers (diagnosed at ages 15 to 39 years) and 256,964 adults without a cancer history.
Seventy-five percent of AYA cancer survivors were still alive at more than six years after diagnosis, and 50.0 percent were still alive at more than 16 years. The researchers found that survivors were more likely to report at least one hardship measure in material (e.g., paying bills) and behavioral (e.g., forgoing care due to cost) domains. They were also more likely to report hardship in all three domains (material, psychological, and behavioral). Furthermore, survivors were more likely to report at least one cost-related prescription medication nonadherence behavior.
"Health care providers must recognize this inequity and its impact on survivors' health, and multifaceted interventions are necessary to address underlying causes," the authors write.
© 2021 HealthDay. All rights reserved.
Posted: April 2021
Read this next
WEDNESDAY, May 5, 2021 -- The absolute deficit in screening associated with the COVID-19 pandemic is estimated at 3.9, 3.8, and 1.6 million for breast, colorectal, and prostate...
TUESDAY, May 4, 2021 -- The U.S. Preventive Services Task Force (USPSTF) concludes that evidence is currently insufficient for determining the benefits and harms of most single or...
MONDAY, May 3, 2021 -- Occult brain metastasis is identified in about 4 percent of patients with metastatic renal cell carcinoma (mRCC), according to a study published in the...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.